URSODIOL Safety Questions, URSODIOL Answers
More Here>>Side Effects - FDA Reports 2006-2008
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZWelcome! Patientsville.com provides unique information about URSODIOL. Our extensive database of URSODIOL adverse events and URSODIOL warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.
>> Announcements
Check out our Hospital and Home Care Quality Reports.
Ask Our Health Experts about URSODIOL
URSODIOL Safety Reports
Total URSODIOL reports: 16.URSODIOL FDA safety alerts: No.
Reported deaths: 1 Reported hospitalizations: 9.
Take URSODIOL Side Effects Survey or Share Your URSODIOL Story. URSODIOL Usage.
Physician from FRANCE reported URSODIOL problem on Jan 03, 2007. Male patient, 74 years of age, was diagnosed with cholangitis sclerosing and was treated with URSODIOL. After drug was administered, patient experienced the following problems/side effects: diarrhoea haemorrhagic. URSODIOL dosage: 500MG BID PO. During the same period patient was treated with INEXIUM, MIANSERIN, CLONAZEPAM. Patient was hospitalized. Patient recovered.
URSODIOL problem was reported by a Consumer or non-health professional from FRANCE on Apr 26, 2007. Female patient, 62 years of age, was diagnosed with cholangitis sclerosing, enterocolitis haemorrhagic and was treated with URSODIOL. After drug was administered, patient experienced the following problems/side effects: hypoplastic anaemia, no therapeutic response, platelet count decreased, platelet count increased, proctocolitis. URSODIOL dosage: 750MG ORAL. During the same period patient was treated with IMURAN, INEXIUM, PENTASA, FOSAMAX, CETIRIZINE. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from JAPAN reported URSODIOL problem on May 04, 2007. Female patient, 55 years of age, was treated with URSODIOL. After drug was administered, patient experienced the following problems/side effects: interstitial lung disease. URSODIOL dosage: 600MG. During the same period patient was treated with ACTARIT, METHOTREXATE, FAMOTIDINE, DICLOFENAC. Patient died.
URSODIOL problem was reported by a Consumer or non-health professional from FRANCE on May 09, 2007. Female patient was diagnosed with cholestasis of pregnancy and was treated with URSODIOL. URSODIOL dosage: 14MG/KG FROM WEEK 31 TO 34 AND 35 TO 39 OF GESTATION. During the same period patient was treated with BETAMETHASONE, CHOLESTYRAMINE. Patient was hospitalized. Patient died.
Consumer or non-health professional from UNITED STATES reported URSODIOL problem on June 11, 2007. Female patient, weighting 7.13 lb, was diagnosed with cholestasis, accidental exposure, coagulopathy and was treated with URSODIOL. After drug was administered, patient experienced the following problems/side effects: pneumomediastinum, pneumothorax. URSODIOL dosage: DAILY DOSE: 1500 MILLIGRAM(S). During the same period patient was treated with PROMETRIUM, VITAMIN K. Patient recovered.
URSODIOL problem was reported by a Consumer or non-health professional from JAPAN on July 06, 2006. Female patient, 82 years of age, was treated with URSODIOL. After drug was administered, patient experienced the following problems/side effects: cough, interstitial lung disease. URSODIOL dosage: 300 MG, PO. Patient recovered.
Consumer or non-health professional from JAPAN reported URSODIOL problem on July 06, 2006. Female patient, 73 years of age, was diagnosed with biliary cirrhosis primary and was treated with URSODIOL. After drug was administered, patient experienced the following problems/side effects: gastric cancer, lymphadenopathy, malignant neoplasm progression. URSODIOL dosage: 600 MG PO. Patient was hospitalized. Patient recovered.
URSODIOL problem was reported by a Physician from JAPAN on July 14, 2006. Female patient, 81 years of age, was diagnosed with cholelithiasis and was treated with URSODIOL. After drug was administered, patient experienced the following problems/side effects: blood alkaline phosphatase increased, cholelithiasis, diarrhoea, eosinophil percentage increased, face oedema, gamma-glutamyltransferase increased, hypersensitivity, interstitial lung disease, pain. URSODIOL dosage: 300 MG PO. During the same period patient was treated with CAPTOPRIL, ROCALTROL, MYONABASE, AMLODIPINE BESYLATE. Patient recovered.
Consumer or non-health professional from JAPAN reported URSODIOL problem on July 25, 2006. Female patient, 81 years of age, was diagnosed with cholelithiasis and was treated with URSODIOL. After drug was administered, patient experienced the following problems/side effects: asthma, blood alkaline phosphatase increased, cholelithiasis, diarrhoea, eosinophil count decreased, face oedema, gamma-glutamyltransferase increased, hypersensitivity, interstitial lung disease. URSODIOL dosage: 300 MG PO. During the same period patient was treated with CAPTOPRIL, ROCALTROL, MYONABASE, AMLODIPINE BESYLATE. Patient recovered.
URSODIOL problem was reported by a Consumer or non-health professional from JAPAN on Aug 02, 2006. Female patient, 81 years of age, was diagnosed with cholelithiasis and was treated with URSODIOL. After drug was administered, patient experienced the following problems/side effects: blood alkaline phosphatase increased, diarrhoea, eosinophil percentage increased, face oedema, gamma-glutamyltransferase increased, hypersensitivity, interstitial lung disease, musculoskeletal stiffness, oral pain. URSODIOL dosage: 300 MG, PO. During the same period patient was treated with ROCALTROL, MYONABASE, CAPTORIL, AZEPTIN, AMLODIPINE BESYLATE, THEODUR, PREDNISOLONE, QVAR. Patient recovered.
Consumer or non-health professional from JAPAN reported URSODIOL problem on Aug 21, 2006. Female patient, 35 years of age, was diagnosed with biliary cirrhosis primary and was treated with URSODIOL. After drug was administered, patient experienced the following problems/side effects: autoimmune hepatitis, condition aggravated. URSODIOL dosage: unknown. During the same period patient was treated with CHOLEBINE, MAGNESIUM OXIDE, MUCOSTA, ALOSENN, BEZATOL, STRONGER NEO MINOPHAGEN C, LIPITOR. Patient was hospitalized. Patient recovered.
URSODIOL problem was reported by a Consumer or non-health professional from JAPAN on Sept 14, 2006. Male patient, 73 years of age, was diagnosed with biliary cirrhosis primary and was treated with URSODIOL. After drug was administered, patient experienced the following problems/side effects: bile duct stone, cholelithiasis, jaundice cholestatic. URSODIOL dosage: unknown. During the same period patient was treated with AMLODIPINE BESYLATE, BEZAFIBRATE. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from JAPAN reported URSODIOL problem on Oct 12, 2006. Female patient, 73 years of age, was diagnosed with biliary cirrhosis primary and was treated with URSODIOL. After drug was administered, patient experienced the following problems/side effects: gastric cancer, hepatic lesion, lymphadenopathy. URSODIOL dosage: 600 MG PO. Patient was hospitalized. Patient recovered.
URSODIOL problem was reported by a Consumer or non-health professional from JAPAN on Dec 14, 2006. Male patient, 59 years of age, was diagnosed with hepatitis c, prinzmetal angina, gastric ulcer, hyperlipidaemia and was treated with URSODIOL. After drug was administered, patient experienced the following problems/side effects: condition aggravated, hepatitis c. URSODIOL dosage: 300 MG, 600 MG, PO. During the same period patient was treated with NIKORANMART, BUFFERIN, PROMAC, PRAVASTATIN, LANSOPRAZOLE. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from JAPAN reported URSODIOL problem on Dec 08, 2006. Male patient, 61 years of age, was diagnosed with hepatitis c, chronic hepatitis and was treated with URSODIOL. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, interstitial lung disease. URSODIOL dosage: 300 MG, PO. During the same period patient was treated with PEGINTRON, RIBAVIRIN. Patient recovered.
URSODIOL problem was reported by a Consumer or non-health professional from JAPAN on Dec 07, 2006. Male patient, 49 years of age, was diagnosed with liver disorder and was treated with URSODIOL. After drug was administered, patient experienced the following problems/side effects: hepatic function abnormal. URSODIOL dosage: 300 MG, PO. During the same period patient was treated with COSPANON. Patient was hospitalized. Patient recovered.
This
drug has an active FDA Safety Alert